141 related articles for article (PubMed ID: 31012882)
1. Intratumoral delivery of M-CSF by calcium crosslinked polymer micelles enhances cancer immunotherapy.
Mao K; Cong X; Feng L; Chen H; Wang J; Wu C; Liu K; Xiao C; Yang YG; Sun T
Biomater Sci; 2019 Jun; 7(7):2769-2776. PubMed ID: 31012882
[TBL] [Abstract][Full Text] [Related]
2. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
Wang Y; Luan Z; Zhao C; Bai C; Yang K
Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
[TBL] [Abstract][Full Text] [Related]
3. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
Xu Z; Wang Y; Zhang L; Huang L
ACS Nano; 2014 Apr; 8(4):3636-45. PubMed ID: 24580381
[TBL] [Abstract][Full Text] [Related]
5. A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade.
Ruan H; Hu Q; Wen D; Chen Q; Chen G; Lu Y; Wang J; Cheng H; Lu W; Gu Z
Adv Mater; 2019 Apr; 31(17):e1806957. PubMed ID: 30856290
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CSF-1R supports T-cell mediated melanoma therapy.
Sluijter M; van der Sluis TC; van der Velden PA; Versluis M; West BL; van der Burg SH; van Hall T
PLoS One; 2014; 9(8):e104230. PubMed ID: 25110953
[TBL] [Abstract][Full Text] [Related]
7. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
8. Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation.
Li SY; Liu Y; Xu CF; Shen S; Sun R; Du XJ; Xia JX; Zhu YH; Wang J
J Control Release; 2016 Jun; 231():17-28. PubMed ID: 26829099
[TBL] [Abstract][Full Text] [Related]
9. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
10. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
[TBL] [Abstract][Full Text] [Related]
11. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
[TBL] [Abstract][Full Text] [Related]
14. Enhanced nanoparticle accumulation by tumor-acidity-activatable release of sildenafil to induce vasodilation.
Zhang P; Zhang Y; Ding X; Xiao C; Chen X
Biomater Sci; 2020 Jun; 8(11):3052-3062. PubMed ID: 32347852
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fusion protein and DC vaccine in inhibition of mouse B16F10 melanoma tumor.
Zhang Y; Liu X; Wang R; Liu S; Wang Y; Jing L; Louis MDJ; Cao R
Biomed Pharmacother; 2018 Jan; 97():784-792. PubMed ID: 29112931
[TBL] [Abstract][Full Text] [Related]
17. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
18. pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.
Min KH; Min HS; Lee HJ; Park DJ; Yhee JY; Kim K; Kwon IC; Jeong SY; Silvestre OF; Chen X; Hwang YS; Kim EC; Lee SC
ACS Nano; 2015 Jan; 9(1):134-45. PubMed ID: 25559896
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
